咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >Prokinetic effects of a ghreli... 收藏

Prokinetic effects of a ghrelin receptor agonist GHRP-6 in diabetic mice

Prokinetic effects of a ghrelin receptor agonist GHRP-6 in diabetic mice

作     者:Qi Zheng Wen-Cai Qiu Jun Yan Wei-Gang Wang Song Yu Zhi-Gang Wang Kai-Xing Ai 

作者机构:Department of General Surgery The Affiliated Sixth Hospital of Medical School Shanghai Jiaotong University Shanghai 200233 China 

出 版 物:《World Journal of Gastroenterology》 (世界胃肠病学杂志(英文版))

年 卷 期:2008年第14卷第30期

页      面:4795-4799页

核心收录:

学科分类:1002[医学-临床医学] 100201[医学-内科学(含:心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

基  金:National Natural Science Foundation of China  No. 30400429 

主  题:GHRP-6 Diabetes mellitus Gastric emptying Intestinal transit Colonic transit 

摘      要:AIM: To investigate the effects of a ghrelin receptor agonist GHRP-6 on delayed gastrointestinal transit in alloxan-induced diabetic mice. METHODS: A diabetic mouse model was established by intraperitoneal injection with alloxan. Mice were randomized into two main groups: normal mice and diabetic mice treated with GHRP-6 at doses of 0, 20, 50, 100 and 200 μg/kg ip. Gastric emptying (GE), intestinal transit (IT), and colonic transit (CT) were studied in mice after they had a phenol red meal following injection of GHRP-6. Based on the most effective GHRP-6 dosage, atropine was given at 1 mg/kg for 15 rain before the GHRP-6 injection for each measurement. The mice in each group were sacrificed 20 min later and the percentages of GE, IT, and CT were calculated. RESULTS: Percentages of GE, IT, and CT were significantly decreased in diabetic mice as compared to control mice. In the diabetic mice, GHRP-6 improved both GE and IT, but not CT. The most effective dose of GHRP-6 was 200 μg/kg and atropine blocked the prokinetic effects of GHRP-6 on GE and IT. CONCLUSION: GHRP-6 accelerates delayed GE and IT, but has no effect on CT in diabetic mice. GHRP-6 may exert its prokinetic effects via the cholinergic pathway in the enteric nervous system, and therefore, has therapeutic potential for diabetic patients with delayed upper gastrointestinal transit.

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分